Structure Therapeutics reported net income of -$107.41M for the quarter ended Jun 2026. This income statement covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 10.89M | 10.45M | 10.53M | 10.53M | 71.89M | 114.81M | 114.95M | 110.20M | 139.85M | 171.59M | 171.76M | 171.86M | 172.61M | 172.70M | 182.03M | 212.51M | 213.21M | 213.66M |
| Operating items | ||||||||||||||||||
| Research & DevelopmentR&D | 8.49M | 10.18M | 9.16M | 8.36M | 13.13M | 19.41M | 17.52M | 20.04M | 20.68M | 22.05M | 32.60M | 33.49M | 42.87M | 54.71M | 58.99M | 68.69M | 66.51M | 100.06M |
| Selling, General & AdministrativeSG&A | 4.46M | 3.78M | 3.53M | 4.60M | 6.51M | 6.58M | 8.63M | 10.95M | 11.34M | 11.27M | 13.24M | 13.57M | 13.44M | 15.74M | 14.80M | 17.57M | 22.87M | 18.57M |
| Other Operating ExpensesOther Opex | -110.25M | |||||||||||||||||
| Operating ExpensesOpex | 12.95M | 13.96M | 12.69M | 12.96M | 19.65M | 25.99M | 26.14M | 30.99M | 32.02M | 33.32M | 45.84M | 47.06M | 56.31M | 70.45M | 73.79M | -23.99M | 89.38M | 118.63M |
| Operating IncomeOp. Inc | -12.95M | -13.96M | -12.69M | -12.96M | -19.65M | -25.99M | -26.14M | -30.99M | -32.02M | -33.32M | -45.84M | -47.06M | -56.31M | -70.45M | -73.79M | 23.99M | -89.38M | -118.63M |
| EBIT | -12.95M | -13.96M | -12.69M | -12.96M | -19.65M | -25.99M | -26.14M | -30.99M | -32.02M | -33.32M | -45.84M | -47.06M | -56.31M | -70.45M | -73.79M | 23.99M | -89.38M | -118.63M |
| Non-operating items | ||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.04M | -0.05M | 0.35M | 0.90M | 0.26M | -0.54M | 2.69M | 6.18M | -0.61M | -0.40M | 11.95M | 10.72M | -0.10M | 8.93M | 8.18M | 9.19M | -3.25M | 12.71M |
| Net income details | ||||||||||||||||||
| EBT | -13.02M | -13.88M | -12.34M | -12.05M | -17.95M | -23.16M | -23.46M | -24.82M | -26.01M | -25.98M | -33.88M | -36.34M | -46.73M | -61.52M | -65.60M | 29.78M | -75.78M | -105.92M |
| Tax ProvisionsTaxes | 0.06M | 0.06M | 0.07M | -0.12M | 0.03M | 0.12M | 0.41M | -19.32M | 0.03M | 0.05M | 0.09M | -25.84M | 0.10M | 0.14M | 0.11M | -29.89M | 0.19M | 0.23M |
| Profit After TaxPAT | -13.08M | -13.95M | -12.47M | -11.85M | -17.98M | -23.28M | -23.86M | -24.30M | -26.04M | -26.03M | -33.98M | -36.48M | -46.83M | -62.11M | -65.71M | 33.09M | -75.97M | -107.41M |
| Income from Continuing OperationsIncome (Continuing) | -13.08M | -13.95M | -12.42M | -11.94M | -17.98M | -23.28M | -23.86M | -5.50M | -26.04M | -26.03M | -33.98M | -10.50M | -46.83M | -61.66M | -65.71M | 59.67M | -75.97M | -106.16M |
| Consolidated Net IncomeConsol Net Inc. | -13.08M | -13.95M | -12.42M | -11.94M | -17.98M | -23.28M | -23.86M | -5.50M | -26.04M | -26.03M | -33.98M | -10.50M | -46.83M | -61.66M | -65.71M | 59.67M | -75.97M | -106.16M |
| Income towards Parent CompanyParent Net Inc | -13.08M | -13.95M | -12.42M | -11.94M | -17.98M | -23.28M | -23.86M | -5.50M | -26.04M | -26.03M | -33.98M | -10.50M | -46.83M | -61.66M | -65.71M | 59.67M | -75.97M | -106.16M |
| Preferred Dividend PaymentsPref Dividends | 1.51M | |||||||||||||||||
| Net Income towards Common StockholdersNet Income | -13.08M | -15.46M | -12.42M | -11.94M | -17.98M | -23.28M | -23.86M | -5.50M | -26.04M | -26.03M | -33.98M | -10.50M | -46.83M | -61.66M | -65.71M | 59.67M | -75.97M | -106.16M |
| Additional items | ||||||||||||||||||
| EPS (Basic) | -1.20 | -1.42 | -1.18 | -1.09 | -0.25 | -0.20 | -0.21 | -0.05 | -0.19 | -0.18 | -0.20 | -0.07 | -0.27 | -0.36 | -0.37 | 0.34 | -0.35 | -0.49 |
| EPS (Diluted) | -1.44 | -1.64 | -1.27 | -1.25 | -0.25 | -0.20 | -0.21 | -0.05 | -0.19 | -0.18 | -0.20 | -0.07 | -0.27 | -0.36 | -0.37 | 0.34 | -0.35 | -0.49 |
| Shares Outstanding | 10.89M | 10.90M | 10.51M | 10.93M | 71.89M | 114.78M | 114.95M | 110.20M | 139.71M | 148.24M | 171.63M | 157.92M | 172.05M | 172.65M | 175.47M | 177.60M | 217.33M | 217.96M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 9.06M | 9.44M | 9.78M | 9.58M | 71.66M | 114.76M | 114.95M | 110.20M | 139.71M | 148.24M | 171.63M | 157.92M | 172.05M | 172.65M | 175.47M | 177.60M | 217.33M | 217.96M |
| EBITDA | -12.95M | -13.96M | -12.69M | -12.96M | -19.65M | -25.99M | -26.14M | -30.99M | -32.02M | -33.32M | -45.84M | -47.06M | -56.31M | -70.45M | -73.79M | 23.99M | -89.38M | -118.63M |
| Tax Rate | -0.46 | -0.46 | -0.59 | 1.00 | -0.14 | -0.51 | -1.73 | 77.85 | -0.11 | -0.20 | -0.27 | 71.10 | -0.21 | -0.23 | -0.16 | -100.35 | -0.25 | -0.22 |